Therapeutic Activity of Medroxyprogesterone Acetate in Metastatic Breast Cancer: A Correlation Between Estrogen Receptors and Various Dosages-Reference-Cited by-同舟云学术

Therapeutic Activity of Medroxyprogesterone Acetate in Metastatic Breast Cancer: A Correlation Between Estrogen Receptors and Various Dosages

Published:1984 Issue: Volume: Page:243-247
ISSN:0080-0015
Container-title:Recent Results in Cancer Research
language:
Short-container-title:

Author:

De Lena M.,Villa S.,Di Fronzo G.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-82188-2_34

Reference10 articles.

1. Amadori D, Ravaioli A, Barbanti F (1977) The use of medroxyprogesterone acetate in high doses in palliative treatment of advanced mammary carcinoma (clinical experience with 44 cases). Minerva Med 68: 3967–3980

2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–259

3. De Lena M, Brambilla C, Volagussa P, Bonadonna G (1979) High dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy. Cancer Chemother Pharmacol 2: 175–180

4. De Lena M, Brambilla C, Jirillo A (1980) Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapy. Tumori 66: 339–348

5. Di Fronzo G, Bertuzzi A, Ronchi E (1968) An improved criterion for the evaluation of estrogen receptor binding data in human breast cancer. Tumori 64: 259–266

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progestational Agents in the Treatment of Breast Cancer;Cancer Treatment and Research;1988

2. High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer;European Journal of Cancer and Clinical Oncology;1987-12

3. The structure and function of progesterone receptors in breast cancer;Journal of Steroid Biochemistry;1987-01

4. The role of progestins and progesterone receptors in the treatment of breast cancer;Steroids;1984-12